Ulisse Biomed Signs Investment Deal with Global Corporate Finance
Deal News | Aug 07, 2025 | Legal Community Italy
Ulisse Biomed, a company listed on Euronext Growth Milan, specializing in diagnostics, theranostics, and therapeutics, has secured an investment agreement for up to €10 million in equity financing with US-based family office Global Corporate Finance. The deal, assisted by Lexia with partners Francesco Dagnino and Andrea Massimo Maroni, involves the issuance of warrants exercisable within five years and additional capital increases to support warrant exercise worth approximately €5 million. The investment offers Ulisse Biomed an alternative financing route, providing flexibility, speed of execution, and the ability to adjust capital inflow according to strategic and operational needs. The funds will be used to enhance Ulisse Biomed's industrial plan, research and development activities, and possibly undertake extraordinary operations.
Sectors
- Diagnostics and Theranostics
- Finance
Geography
- Italy – Ulisse Biomed is listed on Euronext Growth Milan, indicating its operations and primary market are in Italy.
- United States – Global Corporate Finance, the investor, is a US-based family office, highlighting its geographical relevance.
Industry
- Diagnostics and Theranostics – Ulisse Biomed operates in the diagnostics and theranostics sectors, which are central to the deal.
- Finance – The investment deal involves equity financing, which falls under the financial services sector.
Financials
- €10 million – Equity financing amount agreed with Global Corporate Finance
- €5 million – Additional capital increase amount for warrant exercise
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Ulisse Biomed | Target company | Company | An Italian company active in diagnostics, theranostics, and therapeutics, listed on Euronext Growth Milan. |
| Global Corporate Finance | Investor | Company | A US-based family office providing up to €10 million in equity financing to Ulisse Biomed. |
| Lexia | Legal advisor | Company | A law firm advising Ulisse Biomed on the investment agreement. |
| Francesco Dagnino | Legal advisor | Person | Partner at Lexia, coordinated the deal for Ulisse Biomed. |
| Andrea Massimo Maroni | Legal advisor | Person | Partner at Lexia, coordinated the deal for Ulisse Biomed. |
| Marco Pontiggia | Legal advisor | Person | Associate at Lexia, assisted in the deal. |
| Gabriel Zurlo | Legal advisor | Person | Associate at Lexia, assisted in the deal. |